BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29416770)

  • 1. HPRT1 activity loss is associated with resistance to thiopurine in ALL.
    Yang F; Fang H; Wang D; Chen Y; Zhai Y; Zhou BS; Li H
    Oncotarget; 2018 Jan; 9(2):2268-2278. PubMed ID: 29416770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL.
    Li B; Li H; Bai Y; Kirschner-Schwabe R; Yang JJ; Chen Y; Lu G; Tzoneva G; Ma X; Wu T; Li W; Lu H; Ding L; Liang H; Huang X; Yang M; Jin L; Kang H; Chen S; Du A; Shen S; Ding J; Chen H; Chen J; von Stackelberg A; Gu L; Zhang J; Ferrando A; Tang J; Wang S; Zhou BB
    Nat Med; 2015 Jun; 21(6):563-71. PubMed ID: 25962120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxanthine Phosphoribosyl Transferase 1 Is Upregulated, Predicts Clinical Outcome and Controls Gene Expression in Breast Cancer.
    J Sedano M; I Ramos E; Choudhari R; L Harrison A; Subramani R; Lakshmanaswamy R; Zilaie M; Gadad SS
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32532008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines.
    Chouchana L; Fernández-Ramos AA; Dumont F; Marchetti C; Ceballos-Picot I; Beaune P; Gurwitz D; Loriot MA
    Genome Med; 2015; 7(1):37. PubMed ID: 26015807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells.
    Chen Y; Fang H; Sun H; Wu X; Xu Y; Zhou BS; Li H
    Front Pharmacol; 2023; 14():1331687. PubMed ID: 38259297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
    Karim H; Appell ML; Fotoohi A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
    Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
    Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
    Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
    J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRPS2 mutations drive acute lymphoblastic leukemia relapse through influencing PRPS1/2 hexamer stability.
    Song L; Li P; Sun H; Ding L; Wang J; Li B; Zhou BS; Feng H; Li Y
    Blood Sci; 2023 Jan; 5(1):39-50. PubMed ID: 36742181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
    Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
    Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.
    Misdaq M; Andag R; Oellerich M; Asif AR; von Ahsen N
    Ther Drug Monit; 2012 Oct; 34(5):584-92. PubMed ID: 22972540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.
    Karim H; Hashemi J; Larsson C; Moshfegh A; Fotoohi AK; Albertioni F
    Biochem Biophys Res Commun; 2011 Jul; 411(1):156-61. PubMed ID: 21723252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional analysis of mutations at the human hypoxanthine phosphoribosyl transferase (HPRT1) locus.
    Duan J; Nilsson L; Lambert B
    Hum Mutat; 2004 Jun; 23(6):599-611. PubMed ID: 15146465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.
    Brouwer C; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ; Bökkerink JP; Hoogerbrugge PM; van Wering ER; Veerman AJ; De Abreu RA
    Clin Chim Acta; 2005 Nov; 361(1-2):95-103. PubMed ID: 15990089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.
    Shi PJ; Xu LH; Lin KY; Weng WJ; Fang JP
    J Hematol Oncol; 2016 Feb; 9():12. PubMed ID: 26892465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.